Aspect Biosystems
Aspect Biosystems is a Canadian biotechnology company developing Bioprinted Tissue Therapeutics.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Aspect Biosystems is a Canadian biotechnology company that develops Bioprinted Tissue Therapeutics designed to replace, repair, or supplement biological function in the body. The company's platform integrates AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials to build allogeneic tissue therapeutics. It partners with pharmaceutical and biotech companies to bring cell therapies to the clinic.
History
Aspect Biosystems is a Canadian biotechnology company. It was co-founded by Tamer Mohamed, who serves as CEO. The company develops Bioprinted Tissue Therapeutics designed to replace, repair, or supplement biological function in the body. Its platform integrates AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials to build allogeneic tissue therapeutics. The company partners with pharmaceutical and biotech companies to bring cell therapies to the clinic.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/aspect-biosystems · Editorial policy · How profiles are compiled